Abstract:Background and Aims. There is currently a lack of suitable hematological markers as a complement to pathological factors in predicting the prognosis of patients with gallbladder cancer. The study aimed to investigate the clinical value of preoperative fibrinogen levels in assessing the prognosis of patients with gallbladder cancer after radical surgery. Methods. The study retrospectively analyzed 260 gallbladder cancer patients who underwent radical resection. Time-dependent receiver operating characteristic (ROC) curves were used to calculate the optimal cut-off values of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and fibrinogen. Besides, univariate and multivariate analyses of disease-free survival (DFS) and overall survival (OS) were performed to determine independent markers in peripheral blood. Then, subgroup analyses of fibrinogen in different degrees of differentiation, age, gender, and BMI were performed by log-rank test. Result. The cut-off values of fibrinogen, CEA, and CA19-9 were set at 2.97 g/L, 2.17 ng/mL, and 41.1 U/mL, respectively. The results showed that the preoperative fibrinogen level was associated with tumor size, degree of differentiation, TNM stage, and CA19-9 levels. Multivariate analyses indicated that advanced TNM stage, excessive fibrinogen, CEA, and CA19-9 levels were independent risk factors for postoperative DFS. And gallbladder neck tumors, poor differentiation, cancer nodules, advanced TNM stage, excessive fibrinogen, and CEA levels were independent adverse factors for postoperative OS. Notably, the preoperative excessive fibrinogen was an independent adverse factor for both DFS ( p = 0.044 , HR = 1.629 , 95% CI = 1.014 − 2.618 ) and OS ( p = 0.006 , HR = 2.328 , 95% CI = 1.272 − 4.261 ) in patients with gallbladder cancer. The subgroup analyses further indicated that patients with high-level of fibrinogen had both poorer DFS ( p = 0.002 ) and OS ( p = 0.005 ) than patients with poorly-differentiated gallbladder cancer. And for well-differentiated gallbladder cancer, patients with high fibrinogen levels had poorer OS ( p = 0.004 ), but no significant difference in DFS ( p = 0.062 ). Besides, fibrinogen was more significant in GBC patients with higher BMI (>22.62) or older age (>60 yrs) and was not affected by gender. Conclusion. Elevated preoperative fibrinogen level was independently associated with poor postoperative DFS and OS in patients with gallbladder cancer, especially for poor differentiation.

Preoperative Elevated Plasma Fibrinogen Level Predicts Tumor Recurrence and Poor Prognosis in Patients with Hepatocellular Carcinoma.

Pretransplant Elevated Plasma Fibrinogen Level is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation

The Prognostic Value of Preoperative Fibrinogen in Patients with Radical Cholecystectomy

Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients

Fibrinogen and D-dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes.

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

Prognostic Value of Combined Preoperative Fibrinogen and Neutrophil-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma after Liver Transplantation.

Prognostic Significance of Pretreatment Plasma Fibrinogen in Patients with Hepatocellular and Pancreatic Carcinomas

A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma

A Scoring Model Based on Plasma Fibrinogen Concentration for Predicting Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma

Clinical And Prognostic Significance Of Preoperative Plasma Fibrinogen Levels In Patients With Operable Breast Cancer

Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study

The Preoperative Plasma Fibrinogen Level is an Independent Prognostic Factor for Overall Survival of Breast Cancer Patients Who Underwent Surgical Treatment

Prognostic Value of Combined Preoperative Gamma-Glutamyl Transpeptidase to Platelet Ratio and Fibrinogen in Patients with HBV-related Hepatocellular Carcinoma after Hepatectomy.

Prognostic Value of the Preoperative Neutrophil–Lymphocyte Ratio Combined with Fibrinogen in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Embolization

High Plasma Interleukin-6 Levels Associated with Poor Prognosis of Patients with Advanced Hepatocellular Carcinoma

Sa1860 Apatinib Inhibited Cell Proliferation Directly Through Suppressing VEGF Signaling in Extrahepatic Bile Duct Carcinoma

Clinicopathological and Prognostic Value of Preoperative Plasma Fibrinogen in Gastric Cancer Patients

The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study

Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.